Preparation and anti-bacterial properties of a temperature-sensitive gel containing silver nanoparticles

被引:7
作者
Chen, Meiwan [2 ]
Pan, Xin [2 ]
Wu, Hongmei
Han, Ke [2 ]
Xie, Xiaobao [3 ]
Wedge, D. E. [4 ]
Repka, M. A. [5 ]
Wu, Chuanbin [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Dept Pharmaceut, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Res & Dev Ctr Pharmaceut Engn, Guangzhou 510006, Guangdong, Peoples R China
[3] Guangdong Inst Microbiol, Guangzhou, Guangdong, Peoples R China
[4] Univ Mississippi, USDA, ARS, Thad Cochran Natl Ctr Nat Prod Res, University, MS 38677 USA
[5] Univ Mississippi, Dept Pharmaceut, Sch Pharm, University, MS 38677 USA
来源
PHARMAZIE | 2011年 / 66卷 / 04期
关键词
BACTERIAL VAGINOSIS; NANO-SILVER; SUSCEPTIBILITY; CLINDAMYCIN; HYDROGELS; EFFICACY; WOMEN; COLI;
D O I
10.1691/ph.2011.0158
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
The purpose of this study was to prepare a temperature-sensitive gel containing silver nanoparticles and to investigate its anti-bacterial properties in vitro. The aqueous gel was prepared using Pluronic F127 (18-22%) and Pluronic F68 (3-9%) in a cold method to obtain a proper gelation temperature at 37 degrees C. Viscoelastic properties of the system were measured by rheological measurements and the physicochemical properties were evaluated by MJ-22 Dial-reflex metaloscope and Zetasizer Nano ZS90. The in vitro antimicrobial activity was evaluated by a disk diffusion test, minimum inhibitory concentration, and minimum bactericidal concentration. A temperature-sensitive gel containing silver nanoparticles with 20 wt% F127 and 6 wt% F68 had suitable fluidity at 25 degrees C and was semi-solid at 37 degrees C. Silver nanoparticle size averaged 78.0 nm. The gel optimized formulation achieved a suitable viscosity. The MIC and MBC of the gel ranged from 1.0 to 2.0 mg/L against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. The activity of the gel against these three species was significantly enhanced (p<0.05) compared to 400 mg/L Asimi standard. This optimized silver nanoparticle dosage form demonstrated a high potential for further development for the clinical treatment of bacterial vaginosis.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 27 条
[1]
Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product [J].
Amaral, E ;
Perdigao, A ;
Souza, MH ;
Mauck, C ;
Waller, D ;
Zaneveld, L ;
Faundes, A .
CONTRACEPTION, 2006, 73 (05) :542-547
[2]
Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole [J].
Austin, MN ;
Beigi, RH ;
Meyn, LA ;
Hillier, SL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) :4492-4497
[3]
*CDC, 2008, CDC BACT VAG CTR DIS
[4]
CHOI HG, 1998, INT J PHARMACEUT, V165, P12
[5]
Thermo-sensitive and biodegradable hydrogels based on stereocomplexed Pluronic multi-block copolymers for controlled protein delivery [J].
Chung, Hyun Jung ;
Lee, Yuhan ;
Park, Tae Gwan .
JOURNAL OF CONTROLLED RELEASE, 2008, 127 (01) :22-30
[6]
In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate [J].
El-Kamel, AH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 241 (01) :47-55
[7]
Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use [J].
Jain, Jaya ;
Arora, Sumit ;
Rajwade, Jyutika M. ;
Omray, Pratibha ;
Khandelwal, Sanjeev ;
Paknikar, Kishore M. .
MOLECULAR PHARMACEUTICS, 2009, 6 (05) :1388-1401
[8]
JE A, 2007, OBSTET GYNECOL, V109, P7
[9]
Cost-effectiveness of screening and treatment for bacterial vaginosis in early pregnancy among women at low risk for preterm birth [J].
Kekki, M ;
Kurki, T ;
Kotomäki, T ;
Sintonen, H ;
Paavonen, J .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (01) :27-36
[10]
Construction, application and biosafety of silver nanocrystalline chitosan wound dressing [J].
Lu, Shuanyun ;
Gao, Wenjuan ;
Gu, Hai Ying .
BURNS, 2008, 34 (05) :623-628